Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase product.
Matteo C, Colombini A, Bettini LR, Porcu L, Barzaghi S, Ceruti T, Silvestri D, Amoroso A, Dell'Acqua F, Gotti G, Nastasi C, Zucchetti M, Rizzari C. Matteo C, et al. Among authors: zucchetti m. Pediatr Blood Cancer. 2022 Sep;69(9):e29753. doi: 10.1002/pbc.29753. Epub 2022 May 13. Pediatr Blood Cancer. 2022. PMID: 35561075
L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure.
Rizzari C, Zucchetti M, Conter V, Diomede L, Bruno A, Gavazzi L, Paganini M, Sparano P, Lo Nigro L, Aricò M, Milani M, D'Incalci M. Rizzari C, et al. Among authors: zucchetti m. Ann Oncol. 2000 Feb;11(2):189-93. doi: 10.1023/a:1008368916800. Ann Oncol. 2000. PMID: 10761754 Free article. Clinical Trial.
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma.
Belli C, Piemonti L, D'Incalci M, Zucchetti M, Porcu L, Cappio S, Doglioni C, Allavena P, Ceraulo D, Maggiora P, Dugnani E, Cangi MG, Garassini G, Reni M. Belli C, et al. Among authors: zucchetti m. Cancer Chemother Pharmacol. 2016 Mar;77(3):477-84. doi: 10.1007/s00280-015-2932-3. Epub 2015 Dec 14. Cancer Chemother Pharmacol. 2016. PMID: 26666646 Clinical Trial.
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations.
Ballerini A, Moro F, Nerini IF, Marzo CM, Di Clemente A, Ferrari M, D'Incalci M, Biondi A, Colombini A, Conter V, Porcu L, Cervo L, Rizzari C, Zucchetti M. Ballerini A, et al. Among authors: zucchetti m. Cancer Chemother Pharmacol. 2017 Jun;79(6):1267-1271. doi: 10.1007/s00280-017-3307-8. Epub 2017 Apr 19. Cancer Chemother Pharmacol. 2017. PMID: 28424964
Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein.
Erba E, Romano M, Gobbi M, Zucchetti M, Ferrari M, Matteo C, Panini N, Colmegna B, Caratti G, Porcu L, Fruscio R, Perlangeli MV, Mezzanzanica D, Lorusso D, Raspagliesi F, D'Incalci M. Erba E, et al. Among authors: zucchetti m. Biochem Pharmacol. 2017 Nov 15;144:52-62. doi: 10.1016/j.bcp.2017.08.001. Epub 2017 Aug 4. Biochem Pharmacol. 2017. PMID: 28782526
Application of 3D Mass Spectrometry Imaging to TKIs.
Morosi L, Giordano S, Falcetta F, Frapolli R, Licandro SA, Matteo C, Zucchetti M, Ubezio P, Erba E, Visentin S, D'Incalci M, Davoli E. Morosi L, et al. Among authors: zucchetti m. Clin Pharmacol Ther. 2017 Nov;102(5):748-751. doi: 10.1002/cpt.786. Clin Pharmacol Ther. 2017. PMID: 29023728
213 results